Search This Blog

Tuesday, April 23, 2024

Vertex and TreeFrog Agreement and Collaboration on Cell Therapies for Type 1 Diabetes

 

  • Vertex obtains an exclusive license to TreeFrog's C-StemTM manufacturing technology in type 1 diabetes
  • TreeFrog and Vertex to collaborate on scale-up of fully differentiated, insulin-producing pancreatic islet cells

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.